⌘K
Loading ticker…
Avanos Medical, Inc. · Healthcare · Medical Equipment
As of 2026-06-26, Avanos Medical, Inc. (AVNS) has a 3-month relative strength percentile of 94 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 79. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 0.4%, relative volume 1.29×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 94, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
AVNS is in a stage 2 uptrend, week 11. Currently in a 18-day base; basing ADR 0.4% (broad 1.7%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 0.6% / 59.2%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
AVNS is held by 6 ETFs as of Mar 2026. Top owner: IJR at 0.04% weight, $39M notional. Top 3 carry $74M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.04% | $39M |
| VTIVanguard Total Stock Market ETF | 0.00% | $20M |
| IWMiShares Russell 2000 ETF | 0.02% | $15M |
| VXFVanguard Extended Market ETF | 0.01% | $7M |
| XHEState Street SPDR S&P Health Care Equipment ETF | 1.18% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $894K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AVNS Jan avg: 6.39% median: 10.70% win: 75% σ: 14.53% n: 4 2022-04-12 → 2026-05-29 | AVNS Feb avg: -4.59% median: -5.81% win: 25% σ: 7.95% n: 4 2022-04-12 → 2026-05-29 | AVNS Mar avg: 1.94% median: 2.66% win: 50% σ: 5.65% n: 4 2022-04-12 → 2026-05-29 | AVNS Apr avg: 9.04% median: -8.24% win: 20% σ: 37.53% n: 5 2022-04-12 → 2026-05-29 | AVNS May avg: -1.53% median: 0.16% win: 60% σ: 9.81% n: 5 2022-04-12 → 2026-05-29 | AVNS Jun avg: -0.74% median: -1.29% win: 50% σ: 3.90% n: 4 2022-04-12 → 2026-05-29 (current) | AVNS Jul avg: 2.71% median: -0.25% win: 50% σ: 12.68% n: 4 2022-04-12 → 2026-05-29 | AVNS Aug avg: -4.76% median: -5.96% win: 50% σ: 10.47% n: 4 2022-04-12 → 2026-05-29 | AVNS Sep avg: -4.86% median: -3.54% win: 0% σ: 4.67% n: 4 2022-04-12 → 2026-05-29 | AVNS Oct avg: -8.41% median: -6.55% win: 25% σ: 10.25% n: 4 2022-04-12 → 2026-05-29 | AVNS Nov avg: 11.77% median: 11.52% win: 100% σ: 9.07% n: 4 2022-04-12 → 2026-05-29 | AVNS Dec avg: -4.14% median: -1.88% win: 50% σ: 9.19% n: 4 2022-04-12 → 2026-05-29 |